Skip to main content
Premium Trial:

Request an Annual Quote

Whatman/Schleicher & Schuell and German Clinical Dx Lab to Market Protein Chip-Based Autoimmune Assay

NEW YORK, Aug. 9 (GenomeWeb News) - Whatman/Schleicher & Schuell and the Private Institute for Immunology and Molecular Genetics of Germany plan to market a diagnostic protein biochip for autoimmune diseases they have co-developed, Whatman said yesterday.


The chip, based on Whatman/Schleicher & Schuell's nitrocellulose-coated FAST slides, allows researchers to measure autoantibodies associated with collagenosis and vasculititis-related autoimmune diseases.


At the moment, the chip is being validated for compliance with CE guidelines for in vitro diagnostics. The companies plan to launch the diagnostic test at the end of the year.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.